Another policy proposal
re: pharmaceutical companines.
If you get public funding for your drug, then the length of your patent is reduced proportionately to the amount of funding recieved--if 50% of your funding was public, then your patent is only half as long as it would otherwise be. This clearly won't solve the prescription drug problem, but at least it will prevent so much blatant profiteering off of the public's dollar.
If you get public funding for your drug, then the length of your patent is reduced proportionately to the amount of funding recieved--if 50% of your funding was public, then your patent is only half as long as it would otherwise be. This clearly won't solve the prescription drug problem, but at least it will prevent so much blatant profiteering off of the public's dollar.